Dr. Lauren Curtis, MD

Dr. Curtis practices at Ascension Saint Agnes Hospital in Baltimore, Maryland, part of Ascension Health Alliance.

Dr. Curtis' NPI, 1326239187, was assigned on August 7, 2007. Dr. Curtis holds Maryland license D83107.

Dr. Curtis' primary practice is Ascension Saint Agnes Hospital, at 900 Caton Avenue, Baltimore, MD 21229 in Baltimore City. The practice phone is (410) 368-6000.

Dr. Curtis' primary practice is Ascension Saint Agnes Hospital in Baltimore, Maryland, part of Ascension Health Alliance. Dr. Curtis is also affiliated with Brigham and Women's Hospital. The medical group on file is Johns Hopkins Medicine. Dmand AI also links Dr. Curtis to 4 more hospitals, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Curtis practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Curtis' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Curtis' licenses on file in 2 states: Maryland and Massachusetts.

CMS data shows 774 Medicare services from Dr. Curtis across 7 procedure codes in 2024, for 245 Medicare patients. Medicare paid $63,971 for them.

CMS counts 245 Medicare patients who saw Dr. Curtis in 2024. The largest group is 75 to 84, with 114 patients. 71% of them have high cholesterol, and 70% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Curtis' median patient age at 74, with 52% women.

In 2024, Dr. Curtis wrote 364 Medicare Part D claims for 90 patients. 69% of them were for generic drugs. CMS names the drug for 169 of them, across 6 drugs with 11 or more claims each, at $101,884 in total drug cost. In 2023, CMS named 239 claims across 14 drugs.

Dr. Curtis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Curtis as offering telehealth.

CMS Open Payments shows 6 general payments to Dr. Curtis from 4 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 93% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $110.